NCT07764770

Brief Summary

This prospective randomized clinical trial evaluates the effectiveness of a structured telemonitoring protocol as an adjunct to conservative management in patients with temporomandibular disorder (TMD)-related orofacial pain. Participants receive standardized conservative therapy based on behavioural counselling, habit reversal training, and home-based self-management exercises, with or without structured telemonitoring. Clinical outcomes include pain intensity, mandibular function, and oral behaviours, assessed over a 9-month follow-up period. The study aims to determine whether telemonitoring improves treatment adherence, behavioural modification, and clinical outcomes compared with conventional in-office follow-up.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2025

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2025

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2026

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

July 15, 2026

Completed
26 days until next milestone

First Submitted

Initial submission to the registry

August 10, 2026

Completed
4 days until next milestone

First Posted

Study publicly available on registry

August 14, 2026

Completed
Last Updated

August 14, 2026

Status Verified

January 1, 2021

Enrollment Period

1.4 years

First QC Date

August 10, 2026

Last Update Submit

August 10, 2026

Conditions

Keywords

Temporomandibular Disorders (TMD)Orofacial PainTelemonitoring, TeledentistryBehavioral TherapyConservative Treatment

Outcome Measures

Primary Outcomes (4)

  • Maximum pain-free mouth opening (mm)

    Change in maximum pain-free mouth opening measured in millimetres (mm) as an indicator of mandibular functional improvement.

    Baseline (T0), 3 months (T1), and 9 months (T2)

  • Mandibular lateral excursions (mm)

    Change in right and left mandibular lateral excursion measured in millimetres (mm).

    Baseline (T0), 3 months (T1), and 9 months (T2)

  • Protrusive movement (mm)

    Change in maximum mandibular protrusive movement measured in millimetres (mm).

    Baseline (T0), 3 months (T1), and 9 months (T2)

  • Pain intensity assessed using the Visual Analogue Scale (VAS)

    Change in perceived pain intensity assessed using a 10-cm Visual Analogue Scale (VAS), where higher scores indicate greater pain intensity.

    Baseline (T0), 3 months (T1), and 9 months (T2)

Secondary Outcomes (1)

  • Oral Behaviours Checklist (OBC) score

    Baseline (T0), 3 months (T1), and 9 months (T2)

Study Arms (2)

Telemonitoring group (TG)

EXPERIMENTAL

The TG received an active management protocol consisting of standard myofascial therapy combined with monthly in-office clinical evaluations and weekly structured remote interactions.

Behavioral: Structured Telemonitoring

Control group (CG)

ACTIVE COMPARATOR

CG received conventional care based on monthly in-office clinical follow-up and standard therapeutic instructions without any form of remote monitoring.

Behavioral: Conservative Management

Interventions

Weekly remote monitoring through text messaging and scheduled video consultations, in addition to standard conservative management.

Telemonitoring group (TG)

Behavioural counselling, habit reversal training, and home-based self-management exercises with monthly in-office follow-up.

Control group (CG)

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults aged 18-80 years.
  • Diagnosis of temporomandibular disorder (TMD) according to the Diagnostic Criteria for Temporomandibular Disorders (DC/TMD).
  • Presence of chronic orofacial pain persisting for more than 30 days.
  • Diagnosis of myofascial pain involving the masticatory muscles, with or without headache attributed to TMD.
  • Ability to use a mobile device compatible with telemonitoring procedures.

You may not qualify if:

  • Systemic diseases affecting pain perception or neuromuscular function (including autoimmune, neurological, or neoplastic disorders).
  • History of severe orofacial trauma.
  • Previous major temporomandibular joint surgery.
  • Ongoing orthodontic treatment.
  • Current use of occlusal splints.
  • Current use of muscle relaxants or psychoactive medications.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Magna Graecia University of Catanzaro

Catanzaro, CZ, 88100, Italy

Location

Related Publications (9)

  • Ben El Hammi N, Amessegher F, Moudni S, Jouhadi EM. Physiotherapy Approaches for Temporomandibular Disorders: A Multimodal Conservative Management Strategy. Cureus. 2025 Jul 28;17(7):e88885. doi: 10.7759/cureus.88885. eCollection 2025 Jul.

    PMID: 40881526BACKGROUND
  • Iodice G, Michelotti A, D'Anto V, Martina S, Valletta R, Rongo R. Prevalence of psychosocial findings and their correlation with TMD symptoms in an adult population sample. Prog Orthod. 2024 Oct 14;25(1):39. doi: 10.1186/s40510-024-00538-y.

    PMID: 39397187BACKGROUND
  • Ohrbach R, Michelotti A. The Role of Stress in the Etiology of Oral Parafunction and Myofascial Pain. Oral Maxillofac Surg Clin North Am. 2018 Aug;30(3):369-379. doi: 10.1016/j.coms.2018.04.011. Epub 2018 Jun 1.

    PMID: 29866454BACKGROUND
  • Sycinska-Dziarnowska M, Maglitto M, Wozniak K, Spagnuolo G. Oral Health and Teledentistry Interest during the COVID-19 Pandemic. J Clin Med. 2021 Aug 11;10(16):3532. doi: 10.3390/jcm10163532.

    PMID: 34441828BACKGROUND
  • Saini RS, Chopra S, Assiri YA, Alhamoudi FH, Vaddamanu SK, Chaturvedi M, Kuruniyan MS, Banakar M, Heboyan A. Impact of mHealth and eHealth on oral health literacy: A systematic review. Digit Health. 2025 Jul 21;11:20552076251360955. doi: 10.1177/20552076251360955. eCollection 2025 Jan-Dec.

    PMID: 40718406BACKGROUND
  • Ohrbach R, Dworkin SF. The Evolution of TMD Diagnosis: Past, Present, Future. J Dent Res. 2016 Sep;95(10):1093-101. doi: 10.1177/0022034516653922. Epub 2016 Jun 16.

    PMID: 27313164BACKGROUND
  • Schiffman E, Ohrbach R, Truelove E, Look J, Anderson G, Goulet JP, List T, Svensson P, Gonzalez Y, Lobbezoo F, Michelotti A, Brooks SL, Ceusters W, Drangsholt M, Ettlin D, Gaul C, Goldberg LJ, Haythornthwaite JA, Hollender L, Jensen R, John MT, De Laat A, de Leeuw R, Maixner W, van der Meulen M, Murray GM, Nixdorf DR, Palla S, Petersson A, Pionchon P, Smith B, Visscher CM, Zakrzewska J, Dworkin SF; International RDC/TMD Consortium Network, International association for Dental Research; Orofacial Pain Special Interest Group, International Association for the Study of Pain. Diagnostic Criteria for Temporomandibular Disorders (DC/TMD) for Clinical and Research Applications: recommendations of the International RDC/TMD Consortium Network* and Orofacial Pain Special Interest Groupdagger. J Oral Facial Pain Headache. 2014 Winter;28(1):6-27. doi: 10.11607/jop.1151.

    PMID: 24482784BACKGROUND
  • Peck CC, Goulet JP, Lobbezoo F, Schiffman EL, Alstergren P, Anderson GC, de Leeuw R, Jensen R, Michelotti A, Ohrbach R, Petersson A, List T. Expanding the taxonomy of the diagnostic criteria for temporomandibular disorders. J Oral Rehabil. 2014 Jan;41(1):2-23. doi: 10.1111/joor.12132.

    PMID: 24443898BACKGROUND
  • Manfredini D, Lombardo L, Siciliani G. Temporomandibular disorders and dental occlusion. A systematic review of association studies: end of an era? J Oral Rehabil. 2017 Nov;44(11):908-923. doi: 10.1111/joor.12531. Epub 2017 Jul 2.

    PMID: 28600812BACKGROUND

MeSH Terms

Conditions

Temporomandibular Joint DisordersFacial PainFacial Neuralgia

Interventions

Conservative Treatment

Condition Hierarchy (Ancestors)

Craniomandibular DisordersMandibular DiseasesJaw DiseasesMusculoskeletal DiseasesJoint DiseasesMuscular DiseasesStomatognathic DiseasesPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsFacial Nerve DiseasesMouth DiseasesCranial Nerve DiseasesNervous System Diseases

Intervention Hierarchy (Ancestors)

Therapeutics

Study Officials

  • SELENE BARONE, PhDs, DDS

    Magna Graecia University of Catanzaro

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

August 10, 2026

First Posted

August 14, 2026

Study Start

January 1, 2025

Primary Completion

June 1, 2026

Study Completion

July 15, 2026

Last Updated

August 14, 2026

Record last verified: 2021-01

Data Sharing

IPD Sharing
Will not share

Locations